Brief: GeNeuro Says Results Of ProTEct-MS Study Expected In 2021

Geneuro SA

08/09/2020 06:52

Sept 8 (Reuters) - GENEURO SA  GNRO.PA :
    * RESULTS OF PROTECT-MS STUDY EXPECTED IN 2021
    * TRIAL IS BEING CONDUCTED AT KAROLINSKA INSTITUTET'S
ACADEMIC
SPECIALIST CENTER, STOCKHOLM, SWEDEN
    * ONE-YEAR PROTECT-MS STUDY WILL ENROL 40 PATIENTS WHOSE
DISABILITY PROGRESSES IN ABSENCE OF RELAPSES
    * GENEURO AND KAROLINSKA INSTITUTET'S ACADEMIC SPECIALIST
CENTER
(ASC) TO PRESENT PROTECT-MS STUDY OF TEMELIMAB AT MSVIRTUAL2020
    * LONG-TERM DATA FROM PHASE 2 ANGEL-MS TRIAL CONDUCTED BY
GENEURO

Source text for Eikon:  ID:nBw7CQ384a 
Further company coverage:  GNRO.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))